<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076062/" ref="ordinalpos=4575&amp;ncbi_uid=6307866&amp;link_uid=PMC4076062" image-link="/pmc/articles/PMC4076062/figure/F3/" class="imagepopup">Figure 3.  From: Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"><b>VPA activates the PI3K/Akt signaling pathway in pancreatic cancer cells.</b> Pancreatic cancer cells were incubated with or without 1 mM VPA for 24 h. <b>(A)</b> Quantitative real-time RT-PCR analysis of HER2, HER3, ATM, ATR, and PI3KCA mRNA expression in PANC-1, MIA PaCa-2 and BxPC-3 cells. Data are mean ± SD of a single experiment performed in triplicate, all results were reproducible in three independent experiments. ns P &gt; =0.05; * P &lt; 0.05; ** P &lt; 0.01. <b>(B, C)</b> Western blotting analysis of the expression and phosphorylation of HER3 and Akt (ser 473).</div></div>